April 14, 2014 BV 4 Portfolio Company Celladon Receives Breakthrough Therapy Designation from FDA MYDICAR is First Gene Therapy Reported to Receive Breakthrough Designation from FDA’s Center for Biologics Evaluation and Research (CBER) Read full article Download PDF Version